Use wechat scan QR code < / P > < p > to share with friends and circle of friends < / P > < p > < a target = "_ blank" href=" https://news.163.com/news/search?keyword=%E8%BE%89%E7%91%9E "> Pfizer < / a > and biontech of Germany jointly developed mRNA < a target ="_ blank" href=" https://news.163.com/news/search?keyword=%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97 "> new crown vaccine < / a > is the most important vaccine widely used in western countries. However, due to huge international pressure, the US government recently expressed its support for abandoning the new vaccine_ blank" href=" https://news.163.com/news/search?keyword=%E7%9F%A5%E8%AF%86%E4%BA%A7%E6%9D%83 "> intellectual property rights < / a >, to help poor and less developed countries, the industry generally believes that Pfizer will suffer a heavy loss < p > in response, Albert bourla, CEO of Pfizer, an American pharmaceutical giant, recently wrote an open letter to the company's employees, saying that he was "resolutely" opposed to the issue and hoped to discuss his views "frankly", At the same time, we will "transparently" introduce the "facts and facts" about how Pfizer ensures fair distribution of vaccines < p > (screenshot from Pfizer CEO Albert Bella's open letter, the same below) < / P > < p > at the beginning of the letter, Bella wrote: < / P > < p > "dear colleagues, recently the US trade representative announced that it will discuss whether to give up the intellectual property rights of some new vaccines, which has caused some confusion in the world. Is Pfizer not doing enough to ensure fair and equal distribution of vaccines? Will giving up the right to vaccine lead to a solution or more problems? I will discuss these issues with you in my letter today. " Next, he discusses his view of equality. He wrote: < / P > < p > "fair and equal distribution of vaccines is the Polaris that guides us from the beginning. In order to ensure that every country has access to our new vaccine, two conditions are necessary: 1. The price of the vaccine is acceptable to anyone; 2. There is a reliable production line that can produce enough vaccine for all people. " < p > among them, when explaining how the price of Pfizer's vaccine can be affordable, bura said that Pfizer had achieved this long ago. He wrote: < / P > < p > "as early as June 2020, we had decided to provide our vaccine through price classification. Richer countries need to pay the equivalent of a take away meal and give it free to their people. Middle income countries are priced at about half of the former, while low-income countries are priced at cost. Many extremely poor communities will also get vaccines through donation.... < / P > < p > however, when describing the vaccine production capacity, Bella acknowledged that the vaccine production capacity is indeed "more challenging", but also said that Pfizer is solving the problem of production capacity at a "remarkable" speed, saying that through Pfizer's scientists Pfizer has announced that "it will provide more than 2.5 billion doses of vaccine to the world in 2021", and is "quite confident" to achieve the production of 3 billion doses of vaccine set by Pfizer. He also said Pfizer could produce "four billion doses" by 2022 < p > "these vaccines are not for rich or poor countries, nor for the northern or southern hemisphere, but for all people," he stressed < p > "we have reached an agreement to supply 116 countries, and are in-depth negotiations with more countries on the supply of about 2.7 billion doses of vaccine this year. Once all these agreements are completed, we expect that 40% of these vaccines, or more than 1 billion doses, will be available to low - and middle-income countries this year, "he wrote As one of the elites in the United States and the CEO of an American pharmaceutical giant, Bella naturally realized this contradiction, and gave a "self justified" statement in the following paragraph of the open letter: < / P > < p > "as of today, we have issued about 450 million doses of vaccines, and more of these vaccines have gone to high-income countries. Why is that? After we formulated our price classification policy, we contacted all countries and hoped that they could place orders so that we could prepare goods for them. But the reality is that high-income countries have large stockpiles of vaccines. I was very worried about this, and contacted leaders of many low - and middle-income countries through letters, phone calls, and even text messages, calling on them to stock up vaccines too, because the supply is limited. But most of them chose to place orders with other vaccine manufacturers, some because the technology of mRNA vaccine had not been tested at that time, and some had other options to produce vaccines locally. Others don't even approve of our vaccine. " However, he also said that because other vaccine suppliers could not meet the supply requirements due to technical reasons, most of the countries that did not choose Pfizer vaccine at the beginning began to find Pfizer again and signed supply agreements with Pfizer. He therefore believes that in the second half of 2021, Pfizer's vaccine supply will tend to "balance" between rich and low-income countries, and that by 2022, all countries (with Pfizer's contract) will have enough vaccines < p > here, Geng Zhige thinks that if we simply add the total number of 3 billion and 4 billion doses of vaccine production that Pfizer is expected to achieve in 2021 and 2022, then this number is indeed equivalent to the total population of the world < p > "last week, I took the opportunity to provide these facts to the U.S. trade representative, and explained why the proposal to abandon the intellectual property rights of vaccines would disrupt our ongoing work. This is also the second question I want to talk about. Will the proposal to abandon intellectual property rights for vaccines improve the situation of vaccine supply or lead to more problems? I firmly believe that the answer is the latter. " Then, through some "clever" words, she further explained why it was wrong to give up the intellectual property rights of vaccines First, he said that Pfizer had invested a lot of manpower and material resources to build its new vaccine production capacity from scratch, which led to the development and rapid production of so many life-saving vaccines in a very short period of time. This kind of efficiency is rare in the world < p > here, although he has not explicitly stated that the investment in R & D and production can not be "washed away", his statement has been very obviousThat's what it means < p > "at present, infrastructure is not the bottleneck that we cannot produce more quickly. The scarcity of specific raw materials needed to produce our vaccines is the limit. These 280 different materials or ingredients are produced by suppliers from 19 different countries. Many of these suppliers need a lot of technical and economic support from us to improve their production capacity. At present, almost every gram of raw materials will be immediately transported to our production facilities after production, and will be immediately and reliably converted into vaccines, and then immediately transported to 91 countries around the world that have supply agreements with Pfizer. " However, brother Geng Zhige feels that there are some contradictions here. After all, manufacturers of these scarce raw materials for vaccines do not worry about their partners. Even without Pfizer's investment, other vaccine manufacturers will cooperate with them However, he did not disclose what the so-called "organizations with little experience in vaccine production" are and whether they mean something < p > finally, in the penultimate paragraph of the open letter, Bella could not help but put forward the meaning that Pfizer's investment and cost in developing vaccines could not be "wasted", but he also expressed this meaning "cleverly" by caring about "other companies": < p > < p > at the end of the open letter, Bura said Pfizer will "continue to focus on producing high-quality, safe and effective vaccines and providing them to patients around the world as soon as possible, so as to end this deadly vaccine as soon as possible.". "We will not let politics get in the way of our progress, and we will continue to do what we are best at - creating breakthroughs to save the lives of patients," he said At present, there are different opinions on his open letter on social network. Some people agree with his idea that pharmaceutical companies should not give up the intellectual property rights of vaccines because they have to pay so much for raw materials. But some people think Pfizer is quibbling about its unwillingness to give up its capital interests < p > others put forward the view introduced by Geng Zhige, that is, the biggest problem leading to the dilemma of vaccine in low and middle-income countries is the "last few steps" from vaccine delivery to human injection. Therefore, more funds should be used to solve these problems, so as to better fundamentally solve the problem of vaccination in these countries < p > in short, public opinion under the western capitalist system is bound to continue to argue about this issue
2023-03-22 10:04:33